3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
11
Delirium
3
Central Nervous System Diseases
2
Supratentorial Neoplasms
1
Spinal Cord Neoplasms
1
Pain
1
Neuroinflammatory Diseases
1
Neurofibromatoses
1
Neurocognitive Disorders
1
Neoplasms
1
Meningioma
1
Intracranial Aneurysm
1
Hypoxia
1
Hydrocephalus
1
Headache
1
Epilepsy
1
Emergence Delirium
1
Cerebrovascular Disorders
1
Abdominal Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
16
Hydroxyurea
7
Everolimus
7
Bevacizumab
7
lutetium Lu 177 dotatate
6
gallium Ga 68 dotatate
6
Radiosurgery
6
Proton Therapy
6
Specimen Handling
5
pembrolizumab
4
Surveys and Questionnaires
4
Surgical Procedures, Operative
4
Radiotherapy
4
Imatinib Mesylate
4
Cyclophosphamide
4
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
4
aldesleukin
3
abemaciclib
3
Tranexamic Acid
3
Temozolomide
3
Sunitinib
3
Sodium Chloride
3
Radiotherapy, Intensity-Modulated
3
Observation
3
Nivolumab
3
Ga(III)-DOTATOC
3
90Y-octreotide, DOTA-Tyr(3)-
3
vistusertib
2
trametinib
2
ribociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Meningioma
×
Dexmedetomidine
×
CNS
×
Clear all
NCT07398066
2026-02-09
DEX-NEURO
University of Malaya
Phase NA
Not yet recruiting
60 enrolled